Ligand Pharmaceuticals IncorporatedEquity-NMS: LGND
Equity-NMS: LGND
$72.32
+0.90
(2 May)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$72.32
Open
$72.32
Today’s high
$72.70
Today’s low
$70.86
52W low
$49.24
52W high
$94.57
1Y
-3.14%
5Y
-2.48%
PE
24.25
EPS (TTM)
2.94
Shares O/S
17.71M
Market cap
1.28B
Insights
LGND price is above its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. The Company does this by providing financing, licensing its technologies or both. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs.

This technology has enabled several United States Food and Drug Administration (FDA)-approved products, including Gilead's Veklury, Amgen's Kyprolis, Baxter International's Nexterone, Melinta Therapeutics' Baxdela and Sage Therapeutics' Zulresso. Its technologies also include HepDirect, LTP and BEPro Technology Platform, SUREtechnology Platform (owned by Selexis), and Pelican Expression Technology. It has established multiple alliances, licenses and other business relationships with various pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences and Baxter International. .


FAQs

Can I buy Ligand Pharmaceuticals Incorporated shares in India?
How to buy Ligand Pharmaceuticals Incorporated shares in India?
What is the share price of Ligand Pharmaceuticals Incorporated?
What is the Market Capitalization of Ligand Pharmaceuticals Incorporated?
What is the PE ratio of Ligand Pharmaceuticals Incorporated?
Is Ligand Pharmaceuticals Incorporated a good stock to buy?
In which sector / industry does Ligand Pharmaceuticals Incorporated operate?